These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 16709476)
21. Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease. Spinler SA Pharmacotherapy; 2009 Jul; 29(7):812-21. PubMed ID: 19558255 [TBL] [Abstract][Full Text] [Related]
22. Recent clinical trials of antiplatelet therapy in secondary stroke prevention: expectations and results for application in primary care settings. Lutsep HL Am J Med; 2009 Apr; 122(4 Suppl 2):S21-31. PubMed ID: 19332240 [TBL] [Abstract][Full Text] [Related]
23. The platelet functions in acute febrile mucocutaneous lymph node syndrome and a trial of prevention for thrombosis by antiplatelet agent. Yamada K; Fukumoto T; Shinkai A; Shirahata A; Meguro T Nihon Ketsueki Gakkai Zasshi; 1978 Aug; 41(4):791-802. PubMed ID: 716791 [No Abstract] [Full Text] [Related]
25. Antiplatelet drugs in arterial thrombosis: a review. Tsu EC Am J Hosp Pharm; 1978 Dec; 35(12):1507-15. PubMed ID: 362914 [TBL] [Abstract][Full Text] [Related]
26. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention. Chapman MJ Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923 [TBL] [Abstract][Full Text] [Related]
27. Management of surgical patients receiving anticoagulation and antiplatelet agents. Thachil J; Gatt A; Martlew V Br J Surg; 2008 Dec; 95(12):1437-48. PubMed ID: 18991253 [TBL] [Abstract][Full Text] [Related]
28. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor. Gurbel PA Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887 [TBL] [Abstract][Full Text] [Related]
29. Combination of aspirin and clopidogrel for the prevention of thrombosis: implications for the dental practitioner. Shah PR; Yepes JF; Valenza JA Gen Dent; 2007; 55(6):517-22. PubMed ID: 18050576 [TBL] [Abstract][Full Text] [Related]
31. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries. Motovska Z; Kala P Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914 [TBL] [Abstract][Full Text] [Related]
32. Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial. Serebruany VL; Midei MG; Meilman H; Malinin AI; Lowry DR Int J Clin Pract; 2006 Jul; 60(7):863-6. PubMed ID: 16846403 [TBL] [Abstract][Full Text] [Related]
33. Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronary intervention: the promise of prasugrel? Wiviott SD Cardiol Clin; 2008 Nov; 26(4):629-37. PubMed ID: 18929236 [TBL] [Abstract][Full Text] [Related]
34. Aspirin nonresponse in patients with arterial causes of ischemic stroke: considerations in detection and management. Biller J J Neurol Sci; 2008 Sep; 272(1-2):1-7. PubMed ID: 18534625 [TBL] [Abstract][Full Text] [Related]
35. [To attach great importance to clinical management of Kawasaki disease with coronary arterial lesions]. Huang GY Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):569-70. PubMed ID: 24225285 [No Abstract] [Full Text] [Related]
36. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences. Fisher M; Folland E Am J Ther; 2008; 15(2):137-49. PubMed ID: 18356634 [TBL] [Abstract][Full Text] [Related]
37. New approaches to inhibiting platelets and coagulation. Depta JP; Bhatt DL Annu Rev Pharmacol Toxicol; 2015; 55():373-97. PubMed ID: 25562644 [TBL] [Abstract][Full Text] [Related]
38. Use of antiplatelet agents for prevention of ischemic stroke. Callison RC; Adams HP Neurol Clin; 2008 Nov; 26(4):1047-77, ix. PubMed ID: 19026902 [TBL] [Abstract][Full Text] [Related]
39. Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management. Zuern CS; Lindemann S; Gawaz M Semin Thromb Hemost; 2009 Apr; 35(3):295-306. PubMed ID: 19452405 [TBL] [Abstract][Full Text] [Related]
40. Prevention of thrombosis and embolism in children and adolescents with mechanical valve prostheses: warfarin versus antiplatelet agents. Khitin LM; Sade RM; Bradley SM; Crawford FA; Widener CE; Stroud MR J Heart Valve Dis; 2006 May; 15(3):394-9; discussion 399. PubMed ID: 16784079 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]